A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers

NCT05993806 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: L04RD1
DRUG: L04TD3

Sponsor

Celltrion